Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
21,509 Breast Cancer
clinical trials

Oncology Clinical Trial
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Inova Breast Surgery Fairfax
mi
from
Woodbridge, VA
Click here to add this to my saved trials
Oncology Clinical Trial
CAB-ROR2-ADC Safety and Efficacy Study in Patients With Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Sarah Cannon Research Institute at Health One
mi
from
Denver, CO
Click here to add this to my saved trials
Breast Neoplasms Clinical Trial
Delphinus SoftVue Prospective Case Collection - ARM 1
Status: Enrolling
Updated: 2/7/2018
Saint Elizabeth Hospital
mi
from
Appleton, WI
Click here to add this to my saved trials
Metastatic Triple Negative Breast Cancer Clinical Trial
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
Status: Enrolling, Phase II
Updated: 12/31/1969
Research Site
mi
from
Brasschaat,
Click here to add this to my saved trials
Metastatic Triple Negative Breast Cancer Clinical Trial
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Brick, NJ
Click here to add this to my saved trials
Metastatic Triple Negative Breast Cancer Clinical Trial
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Metastatic Triple Negative Breast Cancer Clinical Trial
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Metastatic Triple Negative Breast Cancer Clinical Trial
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
Metastatic Triple Negative Breast Cancer Clinical Trial
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of ZN-c5 in Subjects With Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of ZN-c5 in Subjects With Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Study of Adagloxad Simolenin (OBI-822) and OBI-821 Versus Placebo Treatment for High Risk Early Stage Triple Negative Breast Cancer Patients (TNBC) Following Neoadjuvant or Adjuvant Chemotherapy.
Status: Enrolling, Phase III
Updated: 12/31/1969
Miami Cancer Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer Clinical Trial
A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Health System
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Oncology Clinical Trial
The ConnectedCancerCare Pilot Study (CCC)
Status: Enrolling
Updated: 12/31/1969
The University of Michigan Rogel Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling, Phase
Updated: 12/31/1969
CARTI Cancer Center
mi
from
Little Rock, AR
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Talazoparib For Neoadjuvant Treatment Of Germline Brca1/2 Mutation Patients With Early Triple-negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
St. Luke's Hospital- Allentown Campus
mi
from
Allentown, PA
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Talazoparib For Neoadjuvant Treatment Of Germline Brca1/2 Mutation Patients With Early Triple-negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
mi
from
Duarte, CA
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Talazoparib For Neoadjuvant Treatment Of Germline Brca1/2 Mutation Patients With Early Triple-negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Tennessee Cancer Specialists
mi
from
Harrogate, TN
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Talazoparib For Neoadjuvant Treatment Of Germline Brca1/2 Mutation Patients With Early Triple-negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Breastlink Medical Group, Inc.
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Talazoparib For Neoadjuvant Treatment Of Germline Brca1/2 Mutation Patients With Early Triple-negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC Hillman Cancer Center UPMC Passavant
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
Talazoparib For Neoadjuvant Treatment Of Germline Brca1/2 Mutation Patients With Early Triple-negative Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Arizona Oncology Associates
mi
from
Tempe, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Cleveland Clinic Akron General
mi
from
Akron, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
McFarland Clinic PC - Ames
mi
from
Ames, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Duluth Clinic Ashland
mi
from
Ashland, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Caldwell
mi
from
Caldwell, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Essentia Health - Deer River Clinic
mi
from
Deer River, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Marshfield Clinic Cancer Center - Eau Claire
mi
from
Eau Claire, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Essentia Health Hibbing Clinic
mi
from
Hibbing, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Hawaii Oncology Inc-POB I
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Essentia Health - Jamestown Clinic
mi
from
Jamestown, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Good Samaritan Medical Center
mi
from
Lafayette, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Fairview Maple Grove Medical Center
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Marshfield Medical Center-Rice Lake
mi
from
Rice Lake, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Ascension Providence Hospitals - Southfield
mi
from
Southfield, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
National Jewish Health-Northern Hematology Oncology
mi
from
Thornton, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Essentia Health Virginia Clinic
mi
from
Virginia, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Kaiser Permanente-Woodland Hills
mi
from
Woodland Hills, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502
Status: Enrolling, Phase
Updated: 12/31/1969
Sanford Cancer Center Worthington
mi
from
Worthington, MN
Click here to add this to my saved trials
Inflammatory Breast Carcinoma Clinical Trial
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Joe Lueken Cancer Center
mi
from
Bemidji, MN
Click here to add this to my saved trials
Inflammatory Breast Carcinoma Clinical Trial
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Marshfield Medical Center-EC Cancer Center
mi
from
Eau Claire, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Lovelace Medical Center-Saint Joseph Square
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
McFarland Clinic PC - Ames
mi
from
Ames, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Caldwell
mi
from
Caldwell, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Medical Campus
mi
from
Macomb, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Macomb Township
mi
from
Macomb, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
PeaceHealth United General Medical Center
mi
from
Sedro-Woolley, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Health System-Tawas City
mi
from
Tawas City, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Advanced Breast Care Center PLLC
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Warren
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Cancer Center Worthington
mi
from
Worthington, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Wellspan Health - York Cancer Center
mi
from
York, PA
Click here to add this to my saved trials
Oncology Clinical Trial
G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Institut Jules Bordet
mi
from
Brussels,
Click here to add this to my saved trials
HER2-Positive Early Breast Cancer Clinical Trial
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Chicago Medical Center; Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
HER2-Positive Early Breast Cancer Clinical Trial
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Oncology, P.A. - Tyler; Tyler Cancer Center
mi
from
Tyler, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Saint Joseph Mercy Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Newland Medical Associates-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Ascension Saint John Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Walter Knox Memorial Hospital
mi
from
Emmett, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Genesee Hematology Oncology PC
mi
from
Flint, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Michigan Breast Specialists-Grosse Pointe Woods
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Lehigh Valley Hospital-Hazleton
mi
from
Hazleton, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Geisinger Cancer Services-Pottsville
mi
from
Pottsville, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Reid Health
mi
from
Richmond, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Oncology Hematology Associates of Saginaw Valley PC
mi
from
Saginaw, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of West Branch
mi
from
West Branch, MI
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen
Status: Enrolling, Phase
Updated: 12/31/1969
Memoral Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Cancer, Breast Clinical Trial
Translating Research Into Practice
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Faulkner Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
The University of Kansas Cancer Center, Westwood Campus
mi
from
Kansas City, KS
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
NEXT Oncology
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Saint Joseph Mercy Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
AtlantiCare Health Park-Cape May Court House
mi
from
Cape May Court House, NJ
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Avera Cancer Institute-Sioux Falls
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Aultman Medical Group Hematology and Oncology
mi
from
Canton, OH
Click here to add this to my saved trials
Triple Negative Breast Neoplasms Clinical Trial
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer.
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Goodyear, AZ
Click here to add this to my saved trials
Triple Negative Breast Neoplasms Clinical Trial
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer.
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Triple Negative Breast Neoplasms Clinical Trial
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer.
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study to Allow Continued Treatment of Patients Who Have Participated in a Spectrum-Sponsored Poziotinib Study
Status: Enrolling, Phase II
Updated: 12/31/1969
Hattiesburg Clinic Hematology/Oncology
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
The Mays Cancer Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
Status: Enrolling, Phase III
Updated: 12/31/1969
Royal North Shore Hospital
mi
from
Sydney,
Click here to add this to my saved trials
Oncology Clinical Trial
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Bergen
mi
from
Montvale, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering @ Rockville
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Nassau
mi
from
Uniondale, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Tom Baker Cancer Centre
mi
from
Calgary,
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Community Cancer Center East
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Drain-Less Abdominally Based Breast Reconstruction Using Lysine-Derived Urethane Adhesive
Status: Upcoming
Updated: 12/31/1969
Cleveland Clinic, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Pivotal Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients
Status: Upcoming, Phase III
Updated: 12/31/1969
Beaumont Royal Oak
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
Status: Upcoming, Phase
Updated: 12/31/1969
Banner University Medical Center South
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Stanford Cancer Institute Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod
Status: Upcoming
Updated: 12/31/1969
UT Southwestern Medical Centre
mi
from
Dallas, TX
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine
Status: Upcoming, Phase II
Updated: 12/31/1969
Chan Soon-Shiong Institute for Medicine
mi
from
El Segundo, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Pivotal Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients
Status: Upcoming, Phase III
Updated: 12/31/1969
Baptist MD Anderson Cancer Physicians
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Breast Reconstruction Following Breast Cancer in Very High Risk Patients
Status: Upcoming
Updated: 12/31/1969
Cleveland Clinic, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Breast Reconstruction Clinical Trial
Integrated Imaging System for In Vivo Visualization of Free Flap Perfusion Using Indocyanine Dye
Status: Upcoming
Updated: 12/31/1969
Cleveland Clinic, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Pivotal Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients
Status: Upcoming, Phase III
Updated: 12/31/1969
Comprehensive Breast Care Center
mi
from
Clearwater, FL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Pivotal Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients
Status: Upcoming, Phase III
Updated: 12/31/1969
Franciscan Breast Surgery
mi
from
Tacoma, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Pivotal Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients
Status: Upcoming, Phase III
Updated: 12/31/1969
Dallas Breast Center
mi
from
Dallas, TX
Click here to add this to my saved trials
1 … 207 208 209 210 211 212 213 214 215